Medical Devices and Equipment Manufacturing Stocks in India with Strong Future Roadmaps as PLI Import Substitution, Healthcare Infrastructure Investment, and Export Growth Reshape a Historically Import-Dependent Sector

India medical devices market FY26: Rs 90,000 Cr+. Poly Medicure MCap Rs 17,546 Cr, PE 56.07 below sector 66.74, ROE 10.37%. Opto Circuits LOSS-MAKING, ROE -20.24% CAUTION, negative equity. Extremely thin listed universe. 2-3 meaningful pure-plays. 5 picks: POLYMEDICURE, OPTOCIRCUIT, TTKHEALTH(ref), NARANG(unlisted ref), TRIVITRON(unlisted ref).

India’s medical devices industry has historically been substantially import-dependent, particularly for higher-technology diagnostic and surgical equipment, prompting government PLI incentives aimed at building domestic manufacturing capability and reducing this import reliance amid rising healthcare infrastructure investment.

For investors, this thin sector shows Poly Medicure as the primary viable option, while Opto Circuits requires significant caution given its distress. All data is as of 26 August 2026.

Click Here – Get Free Investment Predictions

What Are Medical Devices and Equipment Manufacturing Stocks in India?

Medical devices and equipment manufacturing stocks are shares in companies producing disposable medical devices, surgical instruments, and diagnostic equipment. India’s listed universe is thin, anchored by Poly Medicure (disposable medical devices including IV cannulas) and Opto Circuits India (currently distressed medical device exporter), with several other significant manufacturers remaining privately held.

Budget 2026-27 Impact on Medical Devices and Equipment Manufacturing Stocks

Click Here – Get Free Investment Predictions

• PLI scheme for medical devices creating domestic manufacturing incentives for medical devices and equipment manufacturing stocks.
• Growing hospital and healthcare infrastructure investment creating demand for medical devices and equipment manufacturing stocks.
• Import substitution opportunity as India reduces dependence on Chinese and Western medical device imports.
• Export opportunity for quality-certified Indian medical devices and equipment manufacturing stocks to developing markets.
• Rising chronic disease prevalence creating structural demand for disposable medical devices.

5 Medical Devices and Equipment Manufacturing Stocks in India to Watch in 2026

Data as of 25 August 2026. For 52-week high/low, verify at nseindia.com before making any investment decision.

1. Poly Medicure (NSE: POLYMEDICURE)

Poly Medicure is India’s primary listed medical devices and equipment manufacturing stock, producing disposable IV cannulas, infusion sets, and surgical devices for domestic and export markets. Market cap is Rs 17,546 crore. PE is 56.07 (below sector 66.74), ROE is 10.37%, D/E is 0.11. Poly Medicure’s scale and export presence make it the primary viable choice among medical devices and equipment manufacturing stocks.

2. Opto Circuits India (NSE: OPTOCIRCUIT)

Opto Circuits India, once a significant medical device and diagnostic equipment exporter, is currently severely distressed with negative ROE of -20.24% and negative book equity. Market cap is only Rs 54 crore. This medical devices and equipment manufacturing stock requires extreme caution given its financial distress.

Check the Univest Screener for Live Fundamental Data on medical devices and equipment manufacturing stocks

3. Trivitron Healthcare (unlisted reference) (NSE: N/A)

Trivitron Healthcare, a significant Indian diagnostic and medical device manufacturer, remains privately held without public listing access, illustrating the thin nature of India’s listed medical devices and equipment manufacturing stocks universe.

4. Narang Medical (unlisted reference) (NSE: N/A)

Narang Medical, a surgical instrument and hospital furniture manufacturer, similarly remains outside direct public equity access for medical devices and equipment manufacturing stocks investors.

Download the Univest iOS App or Univest Android App to track live prices and expert research.

5. Windlas Biotech (CDMO adjacent reference) (NSE: WINDLAS)

Windlas Biotech, primarily a pharmaceutical contract manufacturer, provides tangential rather than direct medical devices and equipment manufacturing stocks exposure, underscoring the concentrated nature of this listed category around Poly Medicure.

What Factors Affect Medical Devices and Equipment Manufacturing Stocks?

• PLI medical device scheme disbursement as domestic manufacturing indicator for medical devices and equipment manufacturing stocks.
• Poly Medicure’s export order growth as international demand indicator.
• Opto Circuits’ restructuring progress as existential indicator given its severe distress.
• Hospital capital expenditure trends as demand indicator for medical devices and equipment manufacturing stocks.
• Healthcare infrastructure investment data as broader demand indicator.

Benefits of Investing in Medical Devices and Equipment Manufacturing Stocks

• Poly Medicure’s established export presence providing revenue diversification.
• PLI incentives creating import substitution opportunity for medical devices and equipment manufacturing stocks.
• Growing healthcare infrastructure investment providing structural demand.
• High regulatory barriers protecting established manufacturers from easy new entry.
• Export opportunity to developing markets for quality-certified Indian medical devices.

Risks to Consider Before Investing

• Opto Circuits’ severe financial distress requiring extreme caution.
• Extremely thin listed universe limiting diversification for medical devices and equipment manufacturing stocks investors.
• Import competition from established global medical device manufacturers.
• Regulatory certification requirements creating compliance costs.
• Poly Medicure’s premium valuation requiring sustained growth execution.

How to Choose Medical Devices and Equipment Manufacturing Stocks

• Poly Medicure is currently the only viable listed option in this thin sector.
• Avoid Opto Circuits entirely given its severe distress.
• Monitor PLI scheme disbursement and hospital capex trends.
• Accept concentration risk given the thin universe.
• Consider the medical devices and equipment manufacturing stocks sector a smaller satellite holding given limited diversification.

How to Invest in Medical Devices and Equipment Manufacturing Stocks in India

Step 1: Open a SEBI-registered demat account. Univest offers zero-brokerage broking with integrated research, so you can screen, research, and invest in medical devices and equipment manufacturing stocks from one platform.

Step 2: Use the Univest Screener to filter the medical devices and equipment manufacturing stocks sector by PE, ROE, D/E, and revenue growth. This gives you a ranked snapshot of all listed medical devices and equipment manufacturing companies.

Step 3: Review financial statements of your shortlist. Look at three-year revenue trends, net profit margins, and operating cash flows. Single-quarter numbers are not a sufficient basis for long-term allocation in the medical devices and equipment manufacturing stocks sector.

Step 4: Decide on position size based on your risk tolerance. High-growth medical devices and equipment manufacturing stocks carry more volatility than diversified blue-chips. Diversify across two or three names rather than concentrating in one.

Step 5: Set price alerts and monitor quarterly results. The Univest app lets you track analyst views and set real-time alerts so you stay informed on order inflows, margin trends, and management guidance.

Conclusion

India’s medical devices and equipment manufacturing stocks sector is thin, with Poly Medicure as the primary viable listed option at PE 56.07 and ROE 10.37%, while Opto Circuits India requires extreme caution given its severe financial distress. PLI import substitution incentives and growing healthcare infrastructure investment create structural opportunities, though the concentrated listed universe limits diversification. Consult a SEBI-registered investment advisor before making any investment decisions.

FAQs on Medical Devices and Equipment Manufacturing Stocks in India 2026

Which are the medical devices and equipment manufacturing stocks in India in 2026?

Ans. Poly Medicure (POLYMEDICURE) is the primary listed medical devices stock, trading at PE 56.07 with ROE 10.37%. Opto Circuits India (OPTOCIRCUIT) is severely distressed with ROE -20.24% and negative equity, requiring extreme caution.

Why is India’s medical devices listed universe so thin?

Ans. Many significant Indian medical device manufacturers including Trivitron Healthcare and Narang Medical remain privately held, while India’s medical devices industry has historically been substantially import-dependent, limiting the domestic manufacturing base that could support public listings.

What is the PLI scheme for medical devices?

Ans. The government’s Production Linked Incentive scheme for medical devices provides financial incentives for domestic manufacturing investment, aiming to reduce India’s historical dependence on imported medical devices and equipment.

Why is Opto Circuits India in such financial distress?

Ans. Opto Circuits’ negative ROE and negative book equity likely reflect years of accumulated losses, possibly from competitive pressure in its export markets or operational challenges, requiring significant restructuring before any investment consideration.

Why does Poly Medicure trade at such a high PE despite being below sector average?

Ans. Poly Medicure’s PE of 56.07, while below the broader healthcare equipment sector average of 66.74, still reflects growth expectations from its export presence and the structural import substitution opportunity in India’s medical devices market.

How do I invest in medical devices and equipment manufacturing stocks in India?

Ans. Open a demat account with a SEBI-registered broker. Poly Medicure is currently the primary viable listed option. Avoid Opto Circuits given its severe distress. Monitor PLI scheme progress. Consult a SEBI-registered investment advisor before investing.

Investors tracking medical devices and equipment manufacturing stocks should also watch quarterly export data, since medical devices and equipment manufacturing stocks with stronger international revenue diversification tend to weather domestic demand fluctuations better. Overall, medical devices and equipment manufacturing stocks remain a niche but strategically important part of India’s healthcare investment landscape, and medical devices and equipment manufacturing stocks with disciplined capital allocation are best positioned for the import substitution opportunity ahead.

India’s push for domestic import substitution continues to shape the outlook for medical devices and equipment manufacturing stocks, and medical devices and equipment manufacturing stocks with stronger local supply chains stand to benefit most from this structural shift.

Investors comparing medical devices and equipment manufacturing stocks across geographies will note India’s cost advantage remains a durable draw for global buyers of medical devices and equipment manufacturing stocks output.